spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Staccato 

 HSMN NewsFeed - 5 Jun 2020
UCB Acquires Engage Therapeutics: Staccato(R) Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
Devices Drug Delivery Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Jun 2016
Alexza Pharmaceuticals Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2016
Alexza Pharmaceuticals to be Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Aug 2013
Alexza Announces Management Promotions
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Dec 2012
The CHMP Delivers a Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2010
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2010
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jul 2008
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Dec 2007
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2007
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Apr 2007
Advancis Pharmaceutical Appoints New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2007
Anthony Tebbutt Joins Alexza Pharmaceuticals as Senior Vice President, Corporate Strategy & Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2007
Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not Complete
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Nov 2006
Joseph Baker Joins Alexza Pharmaceuticals as Vice President, Commercial Manufacturing & Global Supply Chain
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2006
Advancis Pharmaceutical Submits Proposed Order in Corporate Name Infringement Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Oct 2006
Advancis Pharmaceutical Announces Promotion of Robert Bannon to Vice President, Investor Relations & Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2006
Advancis Pharmaceutical Announces Promotion of Robert C. Low to Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2006
Advancis Pharmaceutical Receives Judgment in Trademark Infringement Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Sep 2006
Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYS
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jun 2006
Advancis Pharmaceutical Signs Contract Sales Agreement With Innovex
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2006
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 31 additional stories matching:
Staccato
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.